China Environmental:Key takeaway from biomass industry specialist call

类别:投资策略 机构:德意志银行 研究员:Thomas Zhu,Michael Tong 日期:2018-02-12

We invited Kaidi Ecological (China’s largest biomass treatment company) to talkabout updates and outlook on China's biomass treatment market. We summarizethe key takeaways below.

    Our sector top pick remains China Everbright Intl (257 HK), which we like forimproving earnings quality and improving free cashflow profile. For more details,please refer to China Environmental: Stronger enforcement, improving cashflow;raising CEI EPS, Target Price, 13 November 2017.

    Policy updates.

    China is vigorously promoting biomass heat/power cogeneration projects, whilenot strongly encouraging power-only projects. Government targets to increasecogeneration capacity significantly in Northern China, yet has no such plan inSouthern China. China has recently scrapped regulations that require 1) there canbe only one biomass treatment project in one county or within a radius of 100km; 2) capacity for biomass power projects cannot exceed 30MW. Kaidi believesthat China’s target to have 13.12GW of biomass capacity installed by 2020 isachievable, if we also include the equivalent power generation capacity fromcogeneration projects.

    Raw material cost.

    The company was able to maintain biomass raw material cost stable in the past10 years, through long-term materials supply contracts, logistics management,intermediary layers elimination, and automated operation.

    Operations.

    Burning forestry residuals and wooden wastes is generally more profitable thanburning straws currently. However, most biomass plants still burn a mix ofdifferent raw materials, as it is hardly feasible to burn only one kind of rawmaterial. The profitability of biomass power plant differs from one county toanother, and there is no general rule on project profitability comparison forNorthern China versus Southern China. Most projects of Kaidi have exclusiverights to operate within a county.

数据推荐

投资评级

更多>>
股票名称最新评级目标价研报
巨化股份 买入 -- 研报
益丰药房 买入 -- 研报
老百姓 买入 -- 研报
大参林 买入 -- 研报
欧普康视 持有 -- 研报
我武生物 买入 -- 研报
泰格医药 买入 -- 研报
爱尔眼科 买入 -- 研报
华兰生物 买入 -- 研报
长春高新 买入 -- 研报
周大生 持有 -- 研报

盈利预测

评级选股>>
股票名称11年EPS12年EPS研报
巨化股份 1.42 0.56 研报
欧普康视 0 0 研报
爱尔眼科 0.51 0.50 研报
老百姓 0 0 研报
大参林 0 0 研报
益丰药房 0 0 研报
华兰生物 1.01 0.74 研报
我武生物 0 0 研报
长春高新 0.94 1.58 研报
泰格医药 0 1.15 研报
周大生 0 0 研报

股票关注度

更多>>
股票名称关注度平均评级最新评级
五粮液 41 持有 买入
伊利股份 36 持有 买入
完美世界 33 持有 买入
隆基股份 32 持有 买入
保利地产 31 买入 持有
中信证券 28 持有 持有
中国国旅 28 持有 买入
广联达 28 持有 持有
新宙邦 28 持有 持有
上汽集团 27 买入 中性
瀚蓝环境 27 持有 持有
泸州老窖 27 持有 买入
五粮液 27 持有 买入
比亚迪 27 持有 持有
三一重工 26 持有 持有
通威股份 26 买入 持有
恒生电子 26 持有 买入

行业关注度

更多>>
行业名称关注度关注股票数买入评级数
电子信息 454 85 213
汽车制造 357 39 191
建筑建材 289 47 149
机械行业 277 52 118
生物制药 238 52 136
化工行业 233 56 89
电子器件 232 51 153
金融行业 219 29 90
酿酒行业 203 15 122
交通运输 176 33 78
有色金属 172 40 35
家电行业 164 14 97
房地产 162 30 95
酒店旅游 160 20 66
商业百货 142 31 76
钢铁行业 140 31 62
服装鞋类 135 20 83